Clinical and treatment effects on /sup 3/H-clonidine and /sup 3/H-imipramine binding in elderly depressed patients

Journal Article · Mon Jun 01 00:00:00 EDT 1987 · Life Sci.; (United States)

DOI:https://doi.org/10.1016/0024-3205(87)90003-8· OSTI ID:5607500

Georgotas, A; Schweitzer, J; McCue, R E; Armour, M; Friedhoff, A J

/sup 3/H-clonidine and /sup 3/H-imipramine binding were measured in depressed patients, 55 years and older. There was no significant difference in either /sup 3/H-clonidine or /sup 3/H-imipramine binding between depressed patients and age- and sex-matched controls. There was no significant correlation between /sup 3/H-clonidine or /sup 3/H-imipramine binding and severity of depression before treatment. There was a significant negative correlation between the K/sub D/ of /sup 3/H-imipramine binding sites and Hamilton score over seven weeks of antidepressant treatment. There was no significant difference between receptor data of responders and nonresponders to antidepressant treatment. 19 references, 2 tables.

• Research Organization: New York Univ. School of Medicine, NY
• OSTI ID: 5607500
• Journal Information: Life Sci.; (United States), Vol. 40:22
• Country of Publication: United States
• Language: English

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
ANTIDEPRESSANTS
BIOCHEMICAL REACTION KINETICS
RECEPTORS
AGED ADULTS
NERVOUS SYSTEM DISEASES
PATIENTS
TRACER TECHNIQUES
TRITIUM COMPOUNDS
CENTRAL NERVOUS SYSTEM AGENTS
DISEASES
DRUGS
ISOTOPE APPLICATIONS
KINETICS
LABELLED COMPOUNDS
MEMBRANE PROTEINS
ORGANIC COMPOUNDS
PROTEINS
PSYCHOTROPIC DRUGS
REACTION KINETICS
550201* - Biochemistry- Tracer Techniques